Skip to content
Search

Latest Stories

Depression in UK doubles during pandemic: ONS

The proportion of people in the UK suffering with depression has almost doubled during the Covid-19 pandemic, official data showed on Tuesday (Aug 18).

The Office for National Statistics (ONS) said 19 per cent of adults reported some form of depression during June, compared with 10 per cent in the nine months to March 2020. Stress and anxiety were the most common types of depression listed by people, it said.


The data raises questions about the wider public health costs of a pandemic that has already left Britain with the highest excess mortality rate among major European countries, according to a recent ONS analysis.

Adults who were young, female, disabled or unable to afford an unexpected expense were most vulnerable to depression during the pandemic, the figures showed.

“This report from the ONS presents some worrying data on the rise of depressive symptoms during the pandemic,” said Elaine Fox, professor of cognitive and affective psychology at the University of Oxford.

Adults who told the ONS they would be unable to afford an unexpected expense of £850 were more likely to experience some form of depression, the data showed.

“These economic factors are likely to play an important role in the nation’s mental health in the coming months and years,” Fox said.

The economy has already sustained an historic blow from the pandemic and the national lockdown it prompted in March.

A 2018 study from the Organization for Economic Co-operation and Development put the cost of mental health problems in Britain at around 4 per cent of its annual economic output.

One in eight adults developed moderate to severe depression during the pandemic, the ONS said. Only one in 25 saw an improvement.

More For You

Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less